Meeder Asset Management’s Astrana Health ASTH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-128
Closed -$5K 2075
2022
Q3
$5K Sell
128
-8
-6% -$366 ﹤0.01% 1597
2022
Q2
$5K Buy
136
+31
+30% +$1.18K ﹤0.01% 1672
2022
Q1
$5K Buy
+105
New +$5.42K ﹤0.01% 1828
2021
Q4
Sell
-867
Closed -$79K 2399
2021
Q3
$79K Buy
+867
New +$73.7K ﹤0.01% 965
2020
Q2
Sell
-101
Closed -$1K 2522
2020
Q1
$1K Buy
+101
New +$1.65K ﹤0.01% 2248
2019
Q3
Sell
-462
Closed -$8K 2279
2019
Q2
$8K Buy
+462
New +$8.39K ﹤0.01% 1537

Other funds holding ASTH

Meeder Asset Management's ASTH Position: Q4 2022 in Review

Meeder Asset Management sold out of Astrana Health (ASTH) in Q4 2022, closing a stake of 128 shares — an estimated $5K sold.

Meeder Asset Management first reported a position in ASTH in Q2 2019 and held it in 6 quarters. The position peaked at $79K in Q3 2021. 130 funds tracked by Wall St. Rank hold ASTH as of Q4 2022.

  • Meeder Asset Management reported no remaining Astrana Health position as of Q4 2022 after selling out during the quarter.
  • Meeder Asset Management sold 128 Astrana Health shares in Q4 2022, an estimated $5K.
  • Meeder Asset Management first reported a position in Astrana Health in Q2 2019 and held it in 6 quarters.
  • Meeder Asset Management's Astrana Health position peaked at $79K in Q3 2021.
  • 130 funds tracked by Wall St. Rank held Astrana Health as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.